NEWS & INSIGHTS
News
Company developments and industry updates from LONSCIENCE.202610
Company News
Lonscience’s Modified New Drug LS205 Approved for Clinical Trials
LS205 officially enters clinical development, marking an important milestone in the company’s neurological drug research and development.
Company News
Official Website of Beijing Longxi Biotechnology Co., Ltd. Goes Live
The official website provides a new window for industry partners, institutions and the public to learn about LONSCIENCE.
Company News
LONSCIENCE Recognized as a Technology-Based SME in Beijing
The recognition reflects continued progress in technological innovation, R&D development and research translation.
Company News
LONSCIENCE Recognized as a Beijing Specialized, Sophisticated, Distinctive and Innovative SME
The company has made further progress in specialized development, technological innovation and R&D capability building.
Company News
LONSCIENCE Recognized as a Beijing Innovative SME
The company's innovation capabilities, R&D system and development potential have received further recognition.